Biota Pharmaceuticals

Industry: Biological products (no diagnostic substances)

Headquarters: California

Overview

Average pay of disclosed executives at Biota Pharmaceuticals

Annual data

2018

On March 11, 2019, Biota Pharmaceuticals reported executive compensation for fiscal year 2018.

NamePositionCompensationDetails
Wouter W. LatourPresident and Chief Executive Officer$850,412
Sean N. TuckerChief Scientific Officer$378,008
John M. HarlandFormer Chief Financial Officer$418,048
Joseph M. PattiFormer President and Chief Executive Officer$1,158,248
Mark P. ColonneseFormer Executive Vice President and Chief Financial Officer$639,381

Joseph M. Patti — Former President and Chief Executive Officer — received the highest compensation: $1,158,248 in total.

In addition, Wouter W. Latour — President and Chief Executive Officer — received a total compensation of $850,412; Mark P. Colonnese received $639,381; John M. Harland received $418,048; Sean N. Tucker received $378,008.

2017

On February 26, 2018, Biota Pharmaceuticals reported executive compensation for fiscal year 2017.

NamePositionCompensationDetails
Joseph M. PattiFormer President and Chief Executive Officer$1,030,183
Mark P. ColonneseFormer Executive Vice President and Chief Financial Officer$607,996

Joseph M. Patti — Former President and Chief Executive Officer — received the highest compensation: $1,030,183 in total.

In addition, Mark P. Colonnese — Former Executive Vice President and Chief Financial Officer — received a total compensation of $607,996.

2016

On September 27, 2016, Biota Pharmaceuticals reported executive compensation for fiscal year 2016.

NamePositionCompensationDetails
Joseph M. PattiPresident, Chief Executive Officer and Director$1,010,432
Russell H. PlumbFormer Executive Chairman and Principal Financial Officer$60,908
Mark P. ColonneseExecutive Vice President and Chief Financial Officer$749,945

Joseph M. Patti — President, Chief Executive Officer and Director — received the highest compensation: $1,010,432 in total.

In addition, Mark P. Colonnese — Executive Vice President and Chief Financial Officer — received a total compensation of $749,945; Russell H. Plumb received $60,908.

2015

On September 27, 2016, Biota Pharmaceuticals reported executive compensation for fiscal year 2015.

NamePositionCompensationDetails
Joseph M. PattiPresident, Chief Executive Officer and Director$1,738,177
Russell H. PlumbFormer Executive Chairman and Principal Financial Officer$619,330

Joseph M. Patti — President, Chief Executive Officer and Director — received the highest compensation: $1,738,177 in total.

In addition, Russell H. Plumb — Former Executive Chairman and Principal Financial Officer — received a total compensation of $619,330.

2014

On September 27, 2016, Biota Pharmaceuticals reported executive compensation for fiscal year 2014.

NamePositionCompensationDetails
Joseph M. PattiPresident, Chief Executive Officer and Director$703,526
Russell H. PlumbFormer Executive Chairman and Principal Financial Officer$984,506

Russell H. Plumb — Former Executive Chairman and Principal Financial Officer — received the highest compensation: $984,506 in total.

In addition, Joseph M. Patti — President, Chief Executive Officer and Director — received a total compensation of $703,526.

2013

On October 2, 2014, Biota Pharmaceuticals reported executive compensation for fiscal year 2013.

NamePositionCompensationDetails
Russell H. PlumbPresident, Chief Executive Officer and Director$2,363,697
Joseph M. PattiExecutive Vice President, Corporate Development and Strategy$1,455,385

Russell H. Plumb — President, Chief Executive Officer and Director — received the highest compensation: $2,363,697 in total.

In addition, Joseph M. Patti — Executive Vice President, Corporate Development and Strategy — received a total compensation of $1,455,385.

2012

On October 1, 2013, Biota Pharmaceuticals reported executive compensation for fiscal year 2012.

NamePositionCompensationDetails
Raafat E.F. FahimFormer President and Chief Executive Officer$3,027,718
Paul KesslerFormer Sr. Vice President, Clinical, Medical and Regulatory Affairs and Chief Medical Officer$1,363,589
Matthew KalnikFormer Sr. Vice President, Strategic Planning & Business Operations$1,257,140

Raafat E.F. Fahim — Former President and Chief Executive Officer — received the highest compensation: $3,027,718 in total.

In addition, Paul Kessler — Former Sr. Vice President, Clinical, Medical and Regulatory Affairs and Chief Medical Officer — received a total compensation of $1,363,589; Matthew Kalnik received $1,257,140.

2011

On October 1, 2013, Biota Pharmaceuticals reported executive compensation for fiscal year 2011.

NamePositionCompensationDetails
Raafat E.F. FahimFormer President and Chief Executive Officer$1,585,993
Paul KesslerFormer Sr. Vice President, Clinical, Medical and Regulatory Affairs and Chief Medical Officer$842,099
Matthew KalnikFormer Sr. Vice President, Strategic Planning & Business Operations$692,793

Raafat E.F. Fahim — Former President and Chief Executive Officer — received the highest compensation: $1,585,993 in total.

In addition, Paul Kessler — Former Sr. Vice President, Clinical, Medical and Regulatory Affairs and Chief Medical Officer — received a total compensation of $842,099; Matthew Kalnik received $692,793.

2010

On October 1, 2013, Biota Pharmaceuticals reported executive compensation for fiscal year 2010.

NamePositionCompensationDetails
Raafat E.F. FahimFormer President and Chief Executive Officer$1,898,427
Paul KesslerFormer Sr. Vice President, Clinical, Medical and Regulatory Affairs and Chief Medical Officer$1,069,813
Matthew KalnikFormer Sr. Vice President, Strategic Planning & Business Operations$845,243

Raafat E.F. Fahim — Former President and Chief Executive Officer — received the highest compensation: $1,898,427 in total.

In addition, Paul Kessler — Former Sr. Vice President, Clinical, Medical and Regulatory Affairs and Chief Medical Officer — received a total compensation of $1,069,813; Matthew Kalnik received $845,243.

2008

On April 22, 2009, Biota Pharmaceuticals reported executive compensation for fiscal year 2008.

NamePositionCompensationDetails
Raafat E.F. FahimPresident, Chief Executive Officer and Acting Chief Financial Officer$1,547,187
Leslie HudsonFormer Interim President and Chief Executive Officer$408,759
Jordan SiegelFormer Senior Vice President of Finance and Administration, Chief Financial Officer and Chief Accounting Officer$365,826
Paul KesslerSenior Vice President Clinical, Medical and Regulatory Affairs$660,265

Raafat E.F. Fahim — President, Chief Executive Officer and Acting Chief Financial Officer — received the highest compensation: $1,547,187 in total.

In addition, Paul Kessler — Senior Vice President Clinical, Medical and Regulatory Affairs — received a total compensation of $660,265; Leslie Hudson received $408,759; Jordan Siegel received $365,826.

2007

On April 22, 2009, Biota Pharmaceuticals reported executive compensation for fiscal year 2007.

NamePositionCompensationDetails
Raafat E.F. FahimPresident, Chief Executive Officer and Acting Chief Financial Officer$944,788
Leslie HudsonFormer Interim President and Chief Executive Officer$975,115
Jordan SiegelFormer Senior Vice President of Finance and Administration, Chief Financial Officer and Chief Accounting Officer$907,136

Leslie Hudson — Former Interim President and Chief Executive Officer — received the highest compensation: $975,115 in total.

In addition, Raafat E.F. Fahim — President, Chief Executive Officer and Acting Chief Financial Officer — received a total compensation of $944,788; Jordan Siegel received $907,136.

2006

On April 22, 2009, Biota Pharmaceuticals reported executive compensation for fiscal year 2006.

NamePositionCompensationDetails
Raafat E.F. FahimPresident, Chief Executive Officer and Acting Chief Financial Officer$826,815
Jordan SiegelFormer Senior Vice President of Finance and Administration, Chief Financial Officer and Chief Accounting Officer$429,663
Thomas H. McLainFormer Chairman, Chief Executive Officer and President$1,258,262
Henrik S. RasmussenFormer Senior Vice President, Clinical, Medical, and Regulatory Affairs$772,467
Mark L. SmithFormer Senior Vice President, Finance, Chief Financial Officer, Chief Accounting Officer, and Treasurer$80,073
Joseph JohnsonFormer Senior Vice President, People, Process and Technology$309,945
Adam E. LogalFormer Interim Chief Financial Officer$335,683

Thomas H. McLain — Former Chairman, Chief Executive Officer and President — received the highest compensation: $1,258,262 in total.

In addition, Raafat E.F. Fahim — President, Chief Executive Officer and Acting Chief Financial Officer — received a total compensation of $826,815; Henrik S. Rasmussen received $772,467; Jordan Siegel received $429,663; Adam E. Logal received $335,683; Joseph Johnson received $309,945; Mark L. Smith received $80,073.